95 related articles for article (PubMed ID: 8814701)
1. Expression of FGFR2 BEK and K-SAM mRNA variants in normal and malignant human breast.
Luqmani YA; Bansal GS; Mortimer C; Buluwela L; Coombes RC
Eur J Cancer; 1996 Mar; 32A(3):518-24. PubMed ID: 8814701
[TBL] [Abstract][Full Text] [Related]
2. Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA.
Gilbert E; Del Gatto F; Champion-Arnaud P; Gesnel MC; Breathnach R
Mol Cell Biol; 1993 Sep; 13(9):5461-8. PubMed ID: 8355693
[TBL] [Abstract][Full Text] [Related]
3. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.
Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M
Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490
[TBL] [Abstract][Full Text] [Related]
4. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.
Luqmani YA; Graham M; Coombes RC
Br J Cancer; 1992 Aug; 66(2):273-80. PubMed ID: 1380281
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells.
Liu JJ; Shay JW; Wilson SE
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2584-93. PubMed ID: 9856768
[TBL] [Abstract][Full Text] [Related]
6. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE.
Tannheimer SL; Rehemtulla A; Ethier SP
Breast Cancer Res; 2000; 2(4):311-20. PubMed ID: 11056689
[TBL] [Abstract][Full Text] [Related]
7. Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences.
Le Guiner C; Plet A; Galiana D; Gesnel MC; Del Gatto-Konczak F; Breathnach R
J Biol Chem; 2001 Nov; 276(47):43677-87. PubMed ID: 11557769
[TBL] [Abstract][Full Text] [Related]
8. Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor.
Champion-Arnaud P; Ronsin C; Gilbert E; Gesnel MC; Houssaint E; Breathnach R
Oncogene; 1991 Jun; 6(6):979-87. PubMed ID: 1648704
[TBL] [Abstract][Full Text] [Related]
9. Novel exons located more than 200 kb downstream of the previously described 3' exon of the K-sam gene for generating activated forms of KGF receptor.
Ueda T; Sasaki H; Aoyagi K; Narikiyo M; Tsubosa Y; Kuwahara Y; Sakamoto H; Mafune K; Yoshida T; Makuuchi M; Terada M
Biochem Biophys Res Commun; 1999 Nov; 265(3):739-45. PubMed ID: 10600490
[TBL] [Abstract][Full Text] [Related]
10. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2).
Orr-Urtreger A; Bedford MT; Burakova T; Arman E; Zimmer Y; Yayon A; Givol D; Lonai P
Dev Biol; 1993 Aug; 158(2):475-86. PubMed ID: 8393815
[TBL] [Abstract][Full Text] [Related]
11. Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer.
Zammit C; Barnard R; Gomm J; Coope R; Shousha S; Coombes C; Johnston C
J Pathol; 2001 May; 194(1):27-34. PubMed ID: 11329138
[TBL] [Abstract][Full Text] [Related]
12. Re-programming of expression of the KGFR and bek variants of fibroblast growth factor receptor 2 during limb regeneration in newts (Notophthalmus viridescens).
Poulin ML; Chiu IM
Dev Dyn; 1995 Apr; 202(4):378-87. PubMed ID: 7626794
[TBL] [Abstract][Full Text] [Related]
13. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity.
Itoh H; Hattori Y; Sakamoto H; Ishii H; Kishi T; Sasaki H; Yoshida T; Koono M; Sugimura T; Terada M
Cancer Res; 1994 Jun; 54(12):3237-41. PubMed ID: 8205545
[TBL] [Abstract][Full Text] [Related]
14. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation.
Ishii H; Yoshida T; Oh H; Yoshida S; Terada M
Mol Cell Biol; 1995 Jul; 15(7):3664-71. PubMed ID: 7791773
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.
Murgue B; Tsunekawa S; Rosenberg I; deBeaumont M; Podolsky DK
Cancer Res; 1994 Oct; 54(19):5206-11. PubMed ID: 7923141
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of fibroblast growth factor 8 in human breast cancer.
Marsh SK; Bansal GS; Zammit C; Barnard R; Coope R; Roberts-Clarke D; Gomm JJ; Coombes RC; Johnston CL
Oncogene; 1999 Jan; 18(4):1053-60. PubMed ID: 10023681
[TBL] [Abstract][Full Text] [Related]
17. Promoter region of the murine fibroblast growth factor receptor 2 (bek/KGFR) gene.
Avivi A; Skorecki K; Yayon A; Givol D
Oncogene; 1992 Oct; 7(10):1957-62. PubMed ID: 1408137
[TBL] [Abstract][Full Text] [Related]
18. Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breast.
Bansal GS; Yiangou C; Coope RC; Gomm JJ; Luqmani YA; Coombes RC; Johnston CL
Br J Cancer; 1995 Dec; 72(6):1420-6. PubMed ID: 8519654
[TBL] [Abstract][Full Text] [Related]
19. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.
Moffa AB; Tannheimer SL; Ethier SP
Mol Cancer Res; 2004 Nov; 2(11):643-52. PubMed ID: 15561780
[TBL] [Abstract][Full Text] [Related]
20. Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast.
Luqmani YA; Mortimer C; Yiangou C; Johnston CL; Bansal GS; Sinnett D; Law M; Coombes RC
Int J Cancer; 1995 Aug; 64(4):274-9. PubMed ID: 7657392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
